Butterfly Network, a digital health company specialising in portable ultrasound technology, has entered a commercial agreement with Mendaera, a Silicon Valley-based firm focused on medical robotics. This partnership marks the first "Powered by Butterfly'' commercialisation collaboration and aims to introduce a novel robotic system utilising Butterfly's Ultrasound-on-Chip technology to the interventional market.
The agreement includes a revenue-sharing model for every unit sold, and Mendaera's robotic technology, compatible with Butterfly's ultrasound device, aims to enhance precision and consistency in image-guided, needle-based interventions. Both companies anticipate submitting the product for FDA approval by 2025, aiming to address workforce shortages and burnout in healthcare by expanding access to high-quality interventional treatment.
Mendaera, formed by a team previously associated with Auris, which exited to Johnson & Johnson, secured $24 million in Series A funding in August 2023. The collaboration leverages Butterfly's Ultrasound-on-Chip platform and Mendaera's expertise in medical robotics to create a comprehensive solution. The joint initiative aims to streamline patient care within the healthcare system by offering an innovative robotic system with broad applications in interventional procedures. For more information about Butterfly Garden and Powered by Butterfly, interested parties can visit the official Butterfly Network website.
Click here to read the original news story.